Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera’s management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET).

A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523245752/en/

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, [email protected]
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., [email protected]

Source: Natera, Inc.

You May Also Be Interested In

• Deep Fission Rejects Distortions in Short-Seller Report
• New Crypto: AlphaPepe Presale Crosses $2.8M Raised While Bitcoin Price Prediction Targets $150,000
• AIMarX at DMEXCO 2026: AI-Driven Programmatic Advertising for Measurable Global Growth